# DESCRIPTION

## TECHNICAL FIELD

- introduce Gallid herpesvirus 3 vector

## BACKGROUND

- describe Marek's disease
- discuss limitations of current vaccines
- motivate need for new vector platforms

## SUMMARY OF THE INVENTION

- describe recombinant Gallid herpesvirus 3 vector
- outline vaccine composition
- summarize methods of administration
- describe methods of treating avian species

## DETAILED DESCRIPTION

- define general terms
- define animal and avian species
- define nucleic acid and related terms
- define gene and related terms
- define recombinant viral vector and related terms
- define protein and related terms
- define antigen and related terms
- define immunological response
- define avian pathogen
- define insertion site
- define expression cassette
- define promoter
- define vaccine

### Recombinant Gallid Herpesvirus 3 (GaHV3; MDV-2) Vector

- define recombinant GaHV3 vector
- describe insertion of heterologous polynucleotide
- specify avian pathogens and their antigens
- detail IBDV VP2 antigen and its variants
- describe ILTV glycoprotein E, I, and B antigens
- detail NDV fusion protein and hemagglutinin neuraminidase antigens
- describe avian influenza A serotype H5, H7, H9 hemagglutinin and H5N1 neuraminidase antig
- detail IBV S1 and S2 glycoprotein antigens
- discuss allelic variants and codon optimization
- outline multiple heterologous polynucleotides and expression cassettes

### An Intermediate Recombinant Gallid Herpesvirus 3 (GaHV3; MDV-2) Vector Comprising One or More Maker(s)

- describe intermediate recombinant Gallid herpesvirus 3 vector

### Methods for Producing a Recombinant Gallid Herpesvirus 3 (GaHV3; MDV-2) Vector

- outline method for producing recombinant Gallid herpesvirus 3 vector
- describe insertion of heterologous polynucleotides into intergenic loci
- detail amplification of Gallid herpesvirus 3 vector in E. coli or avian host cells
- explain replacement of marker(s) with expression cassette

### Vaccines

- describe use of recombinant Gallid herpesvirus 3 vector as vaccine
- outline composition of vaccine with pharmaceutically acceptable carrier
- detail administration of vaccine to subject, such as chicken or other poultry
- explain prophylactic and therapeutic uses of vaccine
- describe storage and dosing of vaccine

### Use of the Vaccine

- outline vaccine administration methods
- specify avian species and pathogens

## EXAMPLES

- describe galK expression cassette insertion into SB-1 virus genome

### Cell Culture and Virus Propagation

- describe cell culture and virus propagation methods

### Virus Growth Curve Studies

- describe virus growth curve studies using real-time PCR

### Serum Neutralization Test

- describe serum neutralization test for IBDV

### Statistical Analysis

- describe statistical analysis methods for comparing replication levels and neutralizing antibody levels

### Analysis of Different Loci to Insert an Expression Cassette

- analyze different loci for inserting expression cassettes into SB-1 genome

### Example 2

- describe replication of rSB-1-UL3/4VP2, rSB-1-UL10/11VP2 and rSB-

### Example 3

- examine immunogenic potential of VP2 protein delivered by recombinant SB-1 vector

### Vaccine Development Against IBDV: Immunization Study

- describe experimental design
- administer vaccines to chicks
- collect blood samples for serological studies
- assess immunogenicity of recombinant SB-1 vaccines
- describe results of neutralizing antibody production
- compare results to commercial vaccine
- describe Example 4: challenge study
- administer vaccines and challenge with IBDV
- describe results of challenge study

